OrbiMed announced on October 15, 2026, that it raised $3 billion in commitments across two new private equity funds.
OrbiMed Private Investments X raised more than $1.9 billion for life sciences venture investments in the U.S. and Europe.
OrbiMed Asia Partners VI raised more than $1 billion for healthcare growth equity and venture capital across Asia—reportedly the firm’s largest Asia-focused fund to date.
Both funds will target biopharmaceuticals, medical devices, diagnostics, and technology-enabled healthcare services. Investors include institutions, endowments, foundations, pension funds, sovereign wealth funds, and family offices.
Sources:
OrbiMed Raises $3 Billion Across Global and Asia Private ...
OrbiMed’s largest-ever Asian fund contributes to $3B war chest
OrbiMed Banks $3 Billion for Two Healthcare Venture Funds
OrbiMed Raises $3 Billion for Global Healthcare Investments
OrbiMed Raises $3 Billion for Two Healthcare Investment Funds | EconoTimes
OrbiMed Raises $3 Billion Across U.S., European and Asian Healthcare Investment Funds
OrbiMed Raises $3 Billion Across Global and Asia Private Equity Funds
Jing Liang 🇺🇦 on X: "$3B raise including a $1B Asia fund. ...
OrbiMed raises $3bn across two life sciences funds - Alternatives Watch
OrbiMed hits $1-bn mark for sixth Asia-focussed PE fund, exceeds target